Scarring Alopecia Biopsy: Lymphocytic vs Neutrophilic

Scarring alopecia biopsy reports usually become clear when you read them as patterns rather than as single “magic” words. Most modern reviews group primary scarring alopecias by the dominant inflammatory cell type — lymphocytic, neutrophilic, mixed, or nonspecific — and then match that pattern to the clinical + trichoscopy picture to narrow the diagnosis. This pattern-based approach is described in major reviews of primary cicatricial alopecias and explains why two people can both have “scarring” but need very different next steps.

Medical note: This article is for general education and does not provide personal medical advice. A biopsy report must be interpreted together with exam + trichoscopy. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapidly worsening loss, see a clinician promptly: When to See a Doctor. Start here: Scalp Biopsy • Scarring Alopecia (Hub) • Scalp Biopsy Results: Terms Explained.

Scarring alopecia biopsy: lymphocytic vs neutrophilic patterns, key report phrases, active-edge sampling, and what changes next. — In scarring alopecia, the biopsy “pattern” (lymphocytic vs neutrophilic vs mixed/nonspecific) often predicts what clinicians do next.

Quick navigation

Key takeaways (fast)
Quality check: was the biopsy set up to succeed?
The big classification: lymphocytic vs neutrophilic vs mixed
Lymphocytic / lichenoid pattern (what it usually points toward)
Neutrophilic / suppurative pattern (what it usually points toward)
Mixed / nonspecific patterns (what “late-stage” can look like)
Report phrase → “what it means” → next step direction
When to re-biopsy (and where)
Related scarring guides (this site)
References

Key takeaways (fast)

Most reports can be read in 2 passes: (1) Is it scarring? (fibrous tracts / follicular dropout / perifollicular fibrosis) and (2) what is the dominant inflammatory cell type (lymphocytes vs neutrophils).
Primary cicatricial alopecias are commonly grouped by infiltrate: lymphocytic, neutrophilic, mixed, or nonspecific — described in major reviews of scarring alopecias.
Biopsy technique matters: a major JAAD review states a 4-mm punch sectioned horizontally at multiple levels is best, and scarring processes should be sampled in active disease (often the edge) — trichoscopy can help select the site.
Neutrophilic pattern often changes the “next test”: it commonly triggers culture/antimicrobial direction because neutrophilic scarring disorders behave like chronic folliculitis patterns (e.g., folliculitis decalvans is described as neutrophilic scarring alopecia).
Nonspecific doesn’t always mean “nothing”: late-stage scar can lose its active inflammatory signature; wrong-site sampling (scar center) is a common reason.

Quality check: was the biopsy set up to succeed?

1) Site: active edge vs shiny center

For scarring alopecia, diagnostic yield is highest when sampling an area where follicles are still present but actively inflamed, usually near the edge/transition zone. Reviews on scarring alopecias emphasize sampling toward the edge and using trichoscopy to find subtle inflammation (rather than sampling the smooth “burned-out” center).

2) Sections: horizontal vs vertical

Horizontal sections help evaluate many follicles at once (counts, patterns, distribution of inflammation). Vertical sections can show interface/lichenoid changes and deeper dermal relationships depending on the question. Many clinicians use two biopsies in complex cases so processing can answer both kinds of questions.

3) Punch size and depth

Multiple technical sources describe 4-mm punch biopsies into subcutaneous fat for alopecia evaluation. Shallow or small samples can miss key follicle levels and push reports toward “nonspecific.”

The big classification: lymphocytic vs neutrophilic vs mixed

Primary cicatricial alopecias are often grouped by the dominant inflammatory cell type: lymphocytic, neutrophilic, mixed, or nonspecific. This framework is described in scarring-alopecia reviews and is useful because it predicts the next-step direction (immune-targeting vs antimicrobial-targeting vs both).

Lymphocytic / lichenoid pattern (what it usually points toward)

What it means: the report is telling you lymphocytes are the main inflammatory driver and the pattern is often “lichenoid” around the upper follicle (infundibulum/isthmus). This commonly aligns with classic lymphocytic scarring entities.

High-yield report words:

“Lichenoid lymphocytic infiltrate” / “interface change”
“Perifollicular fibrosis” (often concentric)
“Loss of sebaceous glands”
“Follicular plugging” (especially in lupus patterns when paired with interface change)

What it commonly maps to on this site:

LPP + FFA (often symptomatic; active edge scale/erythema; biopsy used when uncertain)
Discoid Lupus (DLE) (interface/plugging patterns; may use DIF if needed)
CCCA (central progression; biopsy helps when uncertain)

Neutrophilic / suppurative pattern (what it usually points toward)

What it means: neutrophils (pus-forming cells) dominate the inflammation. Several neutrophilic scarring disorders behave like chronic folliculitis patterns, and authoritative dermatology references describe folliculitis decalvans as a chronic neutrophilic inflammation causing scarring hair loss.

High-yield report words:

“Neutrophilic folliculitis”, “suppurative folliculitis”
“Abscess”, “pustules”, “crust”
“Tufting / tufted follicles” (often mentioned in FD patterns)
“Sinus tracts” / deep suppurative language (more consistent with deep inflammatory patterns)

What it commonly maps to on this site:

Folliculitis Decalvans (FD) (neutrophilic scarring folliculitis; tufting can be a clue)
Dissecting Cellulitis (DCS) (deep inflammatory/scarring patterns)

Next-step direction (high-level): neutrophilic patterns often trigger a “culture/antimicrobial strategy” direction under clinician guidance, because several neutrophilic cicatricial alopecias are treated like chronic inflammatory folliculitis patterns.

Mixed / nonspecific patterns (what “late-stage” can look like)

Mixed: both lymphocytes and neutrophils are prominent, or the report explicitly calls it “mixed.” Some disorders can shift patterns, and secondary infection/inflammation can blur categories.

Nonspecific / late-stage scarring: reports may say “late-stage cicatricial alopecia” with minimal active inflammation. This can happen when the biopsy site is too far into the scar center or when disease has “burned out” into fibrous tracts. In this situation, site selection becomes the key question (re-biopsy from an active edge may be considered if diagnosis remains uncertain).

Report phrase → “what it means” → next step direction

“Fibrous tracts / follicular scars”

Meaning: follicles have been replaced by fibrous tissue (scarring architecture).
Direction: treat as scarring process; focus on activity control if inflammation present.

“Loss of sebaceous glands”

Meaning: supportive clue for lymphocytic scarring patterns (often discussed in LPP/FFA spectrum).
Direction: check for clinical/trichoscopy match to LPP/FFA/CCCA/DLE spectrum.

“Lichenoid lymphocytic infiltrate (upper follicle)”

Meaning: classic lymphocytic scarring signature; often points toward LPP/FFA family in the right pattern.
Direction: clinician-led inflammation control; assess activity at edge.

“Neutrophilic folliculitis / pustules / tufting”

Meaning: neutrophilic scarring folliculitis direction (FD-type patterns are a classic example).
Direction: culture/targeted antimicrobial strategy often considered; treat inflammation early to prevent progression.

When to re-biopsy (and where)

Re-biopsy is most often discussed when the report is “nonspecific” but the clinical picture still strongly suggests scarring alopecia, or when the subtype will change management and the report didn’t capture active inflammation. Technique guidance emphasizes:

Choose an active edge with follicles still present (often the margin), not the shiny center.
Use trichoscopy to select the most inflamed site.
Use a proper punch size (commonly 4 mm) and adequate depth; horizontal sections at multiple levels are often preferred in major guidance.

Related scarring guides (this site)

References (trusted sources)

Last updated: March 06, 2026.